Long COVID Taste Loss Traces to Defects Inside Taste Buds
Persistent taste loss after COVID-19 is not just a vague post-viral complaint. Tissue analysis now points to measurable damage inside the taste bud itself, where signaling machinery appears to falter long after the acute infection has passed. In a study published in Chemical Senses, researchers examined people with taste disturbances lasting more than a year and found abnormalities that help explain why sweet, bitter, and umami perception can remain impaired while salty and sour sensation stays relatively preserved.
The findings matter because taste recovery has often been assumed to follow the same course as smell recovery: gradual improvement, then resolution. For a subset of patients, that pattern does not hold. The study provides direct biological evidence that lingering taste dysfunction can reflect altered cell signaling and altered tissue structure rather than a purely subjective complaint or a passing sensory distortion.
Among 28 adults with persistent taste disturbances after infection, none of whom had been hospitalized, eight had clearly abnormal taste scores. Eleven reported difficulty detecting specific flavors, especially sweet, bitter, and umami. Salty and sour perception was largely intact. That selective pattern immediately suggested a problem in a specific signaling pathway rather than a generalized failure of the entire taste apparatus.
PLCβ2 Signaling Appears Weakened in Affected Patients
Investigators collected small tissue samples from the taste buds of 20 participants and looked for biological abnormalities. One of the most important findings involved reduced messenger RNA for PLCβ2, a protein central to taste transduction in cells that detect sweet, bitter, and umami stimuli. In practical terms, PLCβ2 acts as part of the molecular relay that helps convert a chemical taste stimulus into a signal the brain can interpret.
When that relay is dampened, the signal weakens before it reaches the nervous system. Thomas Finger, PhD, described PLCβ2 as a molecular amplifier inside taste cells, a useful description because it captures the physiology without overstating it: the receptor still senses the stimulus, but the downstream message is less efficient. A reduced signal would be expected to blunt the ability to perceive flavors that depend on this pathway, while leaving other taste qualities less affected.
This helps explain the odd sensory split seen in the cohort. Salty and sour taste use different mechanisms that do not depend on PLCβ2, so those sensations can remain relatively preserved even when sweet, bitter, and umami responses deteriorate. In a clinical setting, that distinction could be easy to miss unless patients are questioned in detail about which flavors have changed and which have not.
One sentence captures the bedside implication: the problem is not uniform loss of taste, but selective failure of taste signaling.
Structural Disorganization Suggests the Injury Is Not Purely Molecular
The tissue findings did not stop at RNA changes. Microscopic examination showed that some participants had taste buds with disrupted cellular organization, while others had normal-appearing structures. The difference suggests that post-COVID taste dysfunction may arise from more than one layer of injury: biochemical impairment in signaling molecules and architectural disturbance within the taste bud itself.
Taste buds normally regenerate quickly. Under ordinary conditions, the cells are renewed every two to four weeks. That rapid turnover has often been used as a reason to expect recovery after a viral illness. Yet the current findings show that the machinery needed for normal signaling may remain abnormal even in a tissue designed to renew itself frequently. The persistence of the defect points to ongoing dysregulation rather than a single transient insult.
A single infected episode may have set off a longer repair problem in the oral sensory epithelium. Viral injury, inflammation, or altered local cell turnover could plausibly disturb the balance of replacement and signaling, although the study does not establish which of those mechanisms is dominant. What it does establish is that the tissue in some patients is not behaving like healthy taste tissue.
Why Sweet, Bitter, and Umami Are the Flavors Most Affected
The pattern of impairment is biologically coherent. Sweet, bitter, and umami sensations converge on intracellular pathways that require PLCβ2 to amplify the signal. Salty and sour do not rely on that same pathway. A patient who says food tastes “flat” may actually be describing a selective loss of these specific flavor channels rather than a total collapse of taste.
That nuance matters for diagnosis and research. If the wrong sensory domain is measured, the defect can be missed. If clinicians assume all taste complaints are interchangeable, they may overlook the possibility that a post-viral injury is affecting only part of the gustatory system. The current study’s tissue-level evidence gives those complaints a concrete biological substrate.
The work also strengthens the case for studying post-COVID sensory symptoms with the same seriousness applied to cardiopulmonary or neurologic sequelae. Sensory loss can alter appetite, food enjoyment, and daily nutrition. In older adults or medically fragile patients, even a partial reduction in taste can affect intake and quality of life. When the symptom persists for a year or longer, it is no longer a minor annoyance.
What This Study Can and Cannot Prove
The cohort was small, and all participants were nonhospitalized, so the findings cannot be generalized to every patient with post-COVID taste complaints. The study also does not prove that reduced PLCβ2 mRNA is the sole cause of the symptom, nor does it establish whether the changes are reversible. Still, the value of the work lies in its directness: it links a long-standing patient complaint to measurable abnormalities in taste buds themselves.
That link creates a clearer research path. Future work will need to determine whether the tissue changes normalize with time, whether the signaling defect can be reversed, and whether any intervention can restore gustatory function. Those questions remain open. So does the broader question of why some people recover taste quickly while others remain impaired long after the acute infection has ended.
For now, the study offers something patients have lacked for more than three years of post-COVID observation: evidence that lingering taste loss can reflect real and specific biological injury, not just a lingering memory of the infection.